» Authors » Gary Rubin

Gary Rubin

Explore the profile of Gary Rubin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 1248
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Riazi A, Aspden T, Rubin G, Ambler G, Jichi F, Mynors-Wallice L, et al.
J Pers Med . 2022 Sep; 12(9). PMID: 36143215
Background: Problem-Solving Treatment (PST) has been used to treat and prevent depression in a variety of settings. However, the impact of PST on improving psychological well-being in those with recent...
2.
Brunetta J, Baril J, de Wet J, Fraser C, Rubin G, Thomas R, et al.
Medicine (Baltimore) . 2022 Jul; 101(28):e29850. PMID: 35839056
Because antiretroviral therapy (ART) is allowing people living with human immunodeficiency virus (PLWH) to survive longer, they are developing more age-related comorbidities. We evaluated the effects of age and gender...
3.
Wright D, Crabb D, Adeleke M, Ambler G, Barton K, Bourne R, et al.
Ophthalmology . 2020 May; 127(10):1313-1321. PMID: 32402553
Purpose: To compare visual field outcomes of ocular hypertensive and glaucoma patients treated first with medical therapy with those treated first with selective laser trabeculoplasty (SLT). Design: Secondary analysis of...
4.
Adeleke M, Ambler G, Barton K, Bourne R, Broadway D, Bunce C, et al.
Ophthalmology . 2020 Feb; 127(4):467-476. PMID: 32005561
Purpose: To determine the efficacy of repeat selective laser trabeculoplasty (SLT) in medication-naive open-angle glaucoma (OAG) and ocular hypertensive (OHT) patients requiring repeat treatment for early to medium-term failure during...
5.
Traber G, Della Volpe-Waizel M, Maloca P, Schmidt-Erfurth U, Rubin G, Roska B, et al.
Ophthalmic Res . 2020 Jan; 63(2):88-96. PMID: 31935739
Glaucoma is the leading cause of irreversible blindness worldwide, with an increasing prevalence. The complexity of the disease has been a major challenge in moving the field forward with regard...
6.
Tzaridis S, Herrmann P, Charbel Issa P, Esposti S, Wagner S, Fruttiger M, et al.
Invest Ophthalmol Vis Sci . 2019 Sep; 60(12):3835-3841. PMID: 31529080
Purpose: To assess the presence of binocular gain in macular telangiectasia type 2 (MacTel) and its correlation to paracentral scotomas. Methods: Sixty-eight patients with MacTel were consecutively recruited for a...
7.
Della Volpe-Waizel M, Traber G, Maloca P, Zinkernagel M, Schmidt-Erfurth U, Rubin G, et al.
Ophthalmic Res . 2019 Jul; 63(2):77-87. PMID: 31352462
Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for...
8.
Marques A, Macedo A, Ramos P, Hernandez Moreno L, Butt T, Rubin G, et al.
Ophthalmic Epidemiol . 2019 Jul; 26(6):378-392. PMID: 31280630
To estimate productivity losses amongst people with impaired vision in Portugal and to investigate explanatory factors associated with non-participation in the labour market. A total of 546 visually impaired individuals...
9.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, et al.
Health Technol Assess . 2019 Jul; 23(31):1-102. PMID: 31264958
Background: Newly diagnosed open-angle glaucoma (OAG) and ocular hypertension (OHT) are habitually treated with intraocular pressure (IOP)-lowering eyedrops. Selective laser trabeculoplasty (SLT) is a safe alternative to drops and is...
10.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, et al.
Lancet . 2019 Mar; 393(10180):1505-1516. PMID: 30862377
Background: Primary open angle glaucoma and ocular hypertension are habitually treated with eye drops that lower intraocular pressure. Selective laser trabeculoplasty is a safe alternative but is rarely used as...